Mesh.i
Checkpoint
PubMed
Racine
Checkpoint
PubMed
Exploration
Accueil
Racine
Racine

Serveur d'exploration Tocilizumab - Checkpoint (PubMed)

Index « Mesh.i » - entrée « Contraindications »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
Contracture < Contraindications < Contrast Media  Facettes :

List of bibliographic references

Number of relevant bibliographic references: 9.
Ident.Authors (with country if any)Title
001157 (2015) Ryota Sakai [Japon] ; Akiko Shibata ; Kentaro Chino ; Tsuneo Kondo ; Ayumi Okuyama ; Hirofumi Takei ; Koichi AmanoCorticosteroid- and cyclophosphamide-free treatment of anti-neutrophil cytoplasmic antibody-associated vasculitis using tocilizumab.
001184 (2015) Florian Obermair [Autriche] ; Herwig PieringerBiological Therapies: Effects of Proinflammatory Pathways and their Inhibition on the Myocardium of Rheumatoid Athritis Patients.
001250 (2014) Alex Diamantopoulos [Éthiopie] ; A. Finckh ; T. Huizinga ; D K Sungher ; L. Sawyer ; D. Neto ; F. DejonckheereTocilizumab in the treatment of rheumatoid arthritis: a cost-effectiveness analysis in the UK.
001622 (2013) Paul Emery [Royaume-Uni] ; Anthony Sebba ; Tom W J. HuizingaBiologic and oral disease-modifying antirheumatic drug monotherapy in rheumatoid arthritis.
001971 (2010) Thao Pham [France] ; Pascal Claudepierre ; Arnaud Constantin ; Michel De Bandt ; Bruno Fautrel ; Laure Gossec ; Jacques-Eric Gottenberg ; Philippe Goupille ; Séverine Guillaume ; Eric Hachulla ; Charles Masson ; Jacques Morel ; Xavier Puéchal ; Alain Saraux ; Thierry Schaeverbeke ; Daniel Wendling ; Eric Bruckert ; Stanislas Pol ; Xavier Mariette ; Jean SibiliaTocilizumab: therapy and safety management.
001982 (2010) Tocilizumab for rheumatoid arthritis.
001A29 (2010) Cheryl A. ThompsonFDA approves tocilizumab to treat rheumatoid arthritis.
001A57 (2009) Masahiro Murayama[Proper usage of biologics for treatment of rheumatoid arthritis].
001A95 (2009) Ryuji Koike [Japon] ; Masayoshi Harigai ; Tatsuya Atsumi ; Koichi Amano ; Shinichi Kawai ; Kazuyoshi Saito ; Tomoyuki Saito ; Masahiro Yamamura ; Tsukasa Matsubara ; Nobuyuki MiyasakaJapan College of Rheumatology 2009 guidelines for the use of tocilizumab, a humanized anti-interleukin-6 receptor monoclonal antibody, in rheumatoid arthritis.

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/TocilizumabV1/Data/PubMed/Checkpoint

HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Checkpoint/Mesh.i -k "Contraindications" 

HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Checkpoint/Mesh.i  \
                -Sk "Contraindications" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/PubMed/Checkpoint/biblio.hfd

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    TocilizumabV1
   |flux=    PubMed
   |étape=   Checkpoint
   |type=    indexItem
   |index=    Mesh.i
   |clé=    Contraindications
}}
Wicri

This area was generated with Dilib version V0.6.34.
Data generation: Fri May 22 09:34:00 2020. Site generation: Sun Mar 28 09:01:19 2021